Market capitalization | €22.98m |
Enterprise Value | €25.54m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 2.12 |
P/S ratio (TTM) P/S ratio | 1.91 |
P/B ratio (TTM) P/B ratio | 1.36 |
Revenue (TTM) Revenue | €12.06m |
EBIT (operating result TTM) EBIT | €-4.13m |
As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.
1 Analyst has issued a forecast aap Implantate:
1 Analyst has issued a forecast aap Implantate:
Jun '24 |
+/-
%
|
||
Revenue | 12 12 |
-
|
|
Gross Profit | 1.86 1.86 |
-
|
|
EBITDA | -2.69 -2.69 |
-
|
EBIT (Operating Income) EBIT | -4.13 -4.13 |
-
|
Net Profit | -4.02 -4.02 |
-
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. It offers trauma and biomaterials products which include anatomical plating system LOCTEQ, cannulated screws, standard plates and screws, bone cements, and mixing systems. The company was founded by Uwe Ahrens in 1990 and is headquartered in Berlin, Germany.
Head office | Germany |
CEO | Rubino Girolamo |
Employees | 101 |
Founded | 1990 |
Website | aap.de |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.